Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
948 studies found for:    "Embolism and Thrombosis"
Show Display Options
Download search resultsDownload the search results for:
"Embolism and Thrombosis" (948 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis Technique
Conditions: Intracranial Embolism and Thrombosis;   Postoperative Complications
Intervention: Device: Proximal anastomosis using Heartstring anastomotic device
2 Completed Stroke Prevention in Sickle Cell Anemia (STOP 1)
Conditions: Anemia, Sickle Cell;   Cerebral Embolism and Thrombosis;   Cerebrovascular Disorders;   Hematologic Diseases;   Hemoglobinopathies
Intervention: Procedure: blood transfusion
3 Completed Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
Conditions: Arrhythmia;   Atrial Fibrillation;   Cardiovascular Diseases;   Cerebral Embolism and Thrombosis;   Cerebrovascular Disorders;   Heart Diseases;   Thrombophlebitis;   Cerebrovascular Accident
Intervention: Drug: warfarin
4 Completed Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
Conditions: Blood Disease;   Anemia, Sickle Cell;   Cerebrovascular Disorders;   Cerebral Embolism and Thrombosis
Intervention:
5 Completed The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Conditions: Embolism and Thrombosis;   Embolism;   Vascular Diseases;   Warfarin;   Venous Thromboembolism;   Thrombosis;   Thromboembolism
Intervention: Other: CYP 2C9 and VKORC1 Testing for Warfarin
6 Completed The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
Condition: Embolism and Thrombosis
Interventions: Drug: Dalteparin;   Drug: Warfarin
7 Completed
Has Results
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Venous Thromboembolism;   Thromboembolism;   Thrombosis;   Embolism and Thrombosis;   Deep Vein Thrombosis;   Arthroplasty, Replacement, Hip
Interventions: Drug: DU-176b 15mg;   Drug: DU-176b 30mg;   Drug: Enoxaparin sodium 20 mg (=2000IU)
8 Completed Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)
Conditions: Venous Thromboembolism;   Embolism and Thrombosis;   Hip Fractures
Intervention: Drug: TTP889
9 Completed
Has Results
Epidemiology of Thromboembolism Disease: A Cohort Study
Conditions: Vascular Diseases;   Embolism and Thrombosis;   Phlebitis;   Venous Insufficiency;   Pulmonary Embolism
Intervention: Other: procedure of Deep Vein Thrombosis (DVT) and PE (Pulmonary Embolism) diagnosis
10 Completed
Has Results
Registry of AngioJet Use in the Peripheral Vascular System
Conditions: Peripheral Vascular Disease;   Embolism and Thrombosis;   Venous Thrombosis
Intervention:
11 Not yet recruiting Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
Conditions: Embolism and Thrombosis of the Radial Artery;   Coronary Heart Disease
Interventions: Device: Glidesheath Slender;   Device: standard 6- French radial sheath
12 Recruiting A Complex Contraception Registry
Conditions: Diabetes;   Cardiovascular Disease;   Epilepsy;   Migraine;   Neurological Disorders;   Cancer;   Bariatric Surgery Candidate;   Organ or Tissue Transplant; Complications;   Lupus Erythematosus, Systemic;   Other Hematologic Conditions;   Other Venous Embolism and Thrombosis
Intervention:
13 Unknown  Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion
Conditions: Intracranial Embolism;   Thrombosis
Intervention: Procedure: transcranial ultrasound in patients treated with iv t-PA
14 Unknown  Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
15 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
16 Completed A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
Condition: Thromboembolism
Interventions: Drug: Certoparin;   Drug: Unfractionated Heparin
17 Completed
Has Results
A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
Condition: Venous Thromboembolism
Interventions: Drug: edoxaban;   Drug: enoxaparin sodium
18 Active, not recruiting Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Conditions: Deep Vein Thrombosis;   Venous Thrombosis
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care
19 Completed Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Enoxaparin/Vitamin K-Antagonist
20 Recruiting Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Recommended VTE pharmacological treatments according to international guidelines

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years